GlaxoSmithKline
GSK
#291
Rank
A$104.98 B
Marketcap
$51.46
Share price
0.73%
Change (1 day)
-3.80%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $5.27

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $5.36. In 2022 the company made an earnings per share (EPS) of $12.99 an increase over its 2021 EPS that were of $4.58.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.27-59.42%
2022$12.99183.39%
2021$4.58-17.83%
2020$5.5821.82%
2019$4.5823.91%
2018$3.70141.48%
2017$1.5364.6%
2016$0.93-90.64%
2015$9.93178.14%
2014$3.57-48.16%
2013$6.8922.63%
2012$5.62-11.32%
2011$6.33230.25%
2010$1.92-70.98%
2009$6.616.76%
2008$6.19-15.14%
2007$7.307.82%
2006$6.7719.61%
2005$5.6618.56%
2004$4.770.36%
2003$4.7550.39%
2002$3.1631.13%
2001$2.41-25.43%
2000$3.2331.58%
1999$2.461.05%
1998$2.43-0.98%
1997$2.46-10.07%
1996$2.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.04-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.85-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.79-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.73 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.87-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$3.06-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.33-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA